First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL

NCT01004497 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Dasatinib
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Daunorubicin
DRUG: Dexamethasone
DRUG: Cytarabine
DRUG: Mitoxantrone

Sponsor

The Catholic University of Korea